A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT00666692 · COMPLETED
Trial details
- NCT number
- NCT00666692
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-01
- Primary completion
- 2008-10-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.